SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
14,766Targets
453Trials
84Drugs
7Datasets
6,987Sources
64,683Claims
72,052Evidence
29,649Hypotheses
DRUGpreclinicalaso

e1v1.11

Brand names: E1v1.11, Element-1 ASO

Mechanism

Phosphorodiamidate morpholino (PMO) ASO that blocks Element 1 (E1), an intronic repressor in SMN2 pre-mRNA, de-repressing exon 7 inclusion. Mechanism distinct from nusinersen (which blocks 3' splice site).

Approved indications

SMA preclinical (severe SMNΔ7 mouse)

Related claims (0)

No claims matched “e1v1.11” in free-text search.

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.

Login → Command Center